StonvexLoading…
StonvexStonvexStonvexCore line items from IRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $169.24M | $165.32M | $657.70M | $167.14M | $162.19M |
Operating Income | Not available | Not available | Not available | Not available | Not available |
Net Income | Not available | $-68.00K | $56.56M | $6.89M | $8.05M |
EPS (Diluted) | $0.04 | $0.00 | $0.24 | $0.03 | $0.03 |
Total Assets | Not available | $6.10B | $6.02B | $6.09B | $5.96B |
Total Liabilities | Not available | $2.58B | $2.43B | $2.48B | $2.41B |
Cash & Equivalents | Not available | $23.34M | $23.56M | $23.29M | $19.49M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 235.70M | 237.23M | 239.10M | 233.81M |